EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 48 filers reported holding EVELO BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,643 | -90.8% | 25,695 | -18.0% | 0.00% | – |
| Q4 2022 | $50,451 | -28.9% | 31,336 | -8.0% | 0.00% | – |
| Q3 2022 | $71,000 | -20.2% | 34,065 | -19.0% | 0.00% | – |
| Q2 2022 | $89,000 | -51.4% | 42,039 | -22.1% | 0.00% | – |
| Q1 2022 | $183,000 | -39.4% | 53,959 | +8.2% | 0.00% | – |
| Q4 2021 | $302,000 | +11.4% | 49,857 | +29.5% | 0.00% | – |
| Q3 2021 | $271,000 | -26.4% | 38,492 | +43.7% | 0.00% | – |
| Q2 2021 | $368,000 | +145.3% | 26,779 | +90.4% | 0.00% | – |
| Q1 2021 | $150,000 | +10.3% | 14,063 | +25.3% | 0.00% | – |
| Q4 2020 | $136,000 | +151.9% | 11,219 | +10.1% | 0.00% | – |
| Q3 2020 | $54,000 | -97.8% | 10,194 | -96.2% | 0.00% | -100.0% |
| Q2 2019 | $2,421,000 | +12.1% | 269,645 | -0.1% | 0.00% | 0.0% |
| Q1 2019 | $2,159,000 | -41.9% | 269,819 | -5.5% | 0.00% | 0.0% |
| Q4 2018 | $3,715,000 | -2.9% | 285,543 | -9.1% | 0.00% | 0.0% |
| Q3 2018 | $3,824,000 | -3.8% | 313,963 | -6.8% | 0.00% | 0.0% |
| Q2 2018 | $3,974,000 | – | 336,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 3,063,505 | $37,038,000 | 14.47% |
| Mayo Clinic | 484,953 | $5,863,000 | 7.05% |
| Flagship Pioneering Inc. | 22,900,069 | $276,862,000 | 5.04% |
| Trustees of Columbia University in the City of New York | 113,850 | $1,376,000 | 1.84% |
| Alphabet Inc. | 1,060,495 | $12,821,000 | 0.62% |
| Artal Group S.A. | 700,000 | $8,463,000 | 0.18% |
| Larson Financial Group LLC | 28,353 | $343,000 | 0.12% |
| PEDDOCK CAPITAL ADVISORS, LLC | 3,663 | $44,000 | 0.02% |
| CREDIT SUISSE AG/ | 2,705,511 | $32,710,000 | 0.02% |
| FMR LLC | 6,803,365 | $82,253,000 | 0.01% |